Stockholm Convention invites comments on PFOI/PFOB specific exemption review

The Stockholm Convention Secretariat invites submissions on the draft report reviewing the specific exemption for the use of perfluorooctyl iodide (PFOI) for the production of perfluorooctyl bromide (PFOB) for pharmaceutical product manufacturing. This exemption was listed in Annex A following COP-12 decisions. Comments are due by 22 May 2026.